Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,842 across all filing types
Latest filing 2020-04-01 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
监事会对公司2019年度内部控制自我评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is a supervisory board's opinion on the company's 2019 internal control self-evaluation report. It references internal control evaluation and legal compliance but does not contain full financial statements or detailed financial data. The document is relatively short (515 characters) and serves as an official announcement or opinion rather than the full report itself. This fits best with the Audit Report / Information (AR) category, which includes audit reports and internal control evaluations separate from full annual reports. Therefore, the classification is AR with high confidence. FY 2019
2020-04-01 Chinese
2019年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Self-Evaluation Report" for the year 2019 by 健帆生物科技集团股份有限公司. It discusses the company's internal control evaluation, including financial and non-financial internal control effectiveness, control environment, control procedures, internal audit, and governance structure. The document is detailed and contains substantive content about internal control systems, their evaluation, and related policies. It is not an announcement or a brief summary but a full report on internal control self-assessment. This type of document fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and internal control evaluations, excluding full annual reports. The document is not an Annual Report (10-K) as it does not cover full financial performance or company activity comprehensively, nor is it a Regulatory Filing (RNS) or Report Publication Announcement (RPA) since it contains the full report text and analysis. Therefore, the correct classification is AR with high confidence. FY 2019
2020-04-01 Chinese
关于召开2019年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2019 Annual General Meeting (AGM) of the company, including the meeting time, location, agenda items, voting procedures, and proxy forms. It contains no actual financial statements or results but rather the agenda and procedural information for the AGM. The document includes proposals to be voted on, such as the 2019 annual report, board reports, financial reports, remuneration plans, election of directors, and other governance matters. This is clearly a notice or announcement related to the AGM, not the AGM materials themselves or the voting results. Therefore, the document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or notices about the AGM itself. The document length (9054 characters) and content confirm it is a full AGM notice rather than a brief announcement or a voting result declaration. Hence, the classification is AGM-R with high confidence.
2020-04-01 Chinese
关于选举产生第四届监事会职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of a new employee representative supervisor to the company's supervisory board. It includes details about the election process, the elected individual's background, and compliance with relevant regulations. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of a meeting presentation or voting results. This fits the category of Board/Management Information, as it concerns changes in the company's supervisory board composition.
2020-04-01 Chinese
关于2019年年度报告披露的提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (493 characters) from a company about the disclosure of its 2019 Annual Report. It states that the full 2019 Annual Report and summary will be published on April 2, 2020, on a designated website. The text does not contain the actual annual report or financial data but only informs investors about the report's availability. According to the 'MENU VS MEAL' rule, such a brief notice announcing the publication of a report is classified as a Report Publication Announcement (RPA), not the Annual Report (10-K) itself.
2020-04-01 Chinese
关于筹划公开发行可转换公司债券的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement (430 characters) about the company's plan to publicly issue convertible bonds. It states that the matter is still in the planning stage and has not yet been approved by the board or shareholders. There is no detailed financial data or report content, only a notification of a capital raising plan. This fits the definition of a Capital/Financing Update (CAP) as it relates to fundraising activities and capital structure changes. The document is not a full report, nor an announcement of a report publication, so it is not RPA or RNS. Therefore, the correct classification is CAP with high confidence.
2020-03-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.